Colette Dejong, MD
ACGME/ABMS Fellow
Medicine
School of Medicine

Publications (37)

Top publication keywords:
Conflict of InterestBetacoronavirusHealth ExpendituresTetrazolesHydroxychloroquineHealth Care RationingDrug CostsResource AllocationAngiotensin-Converting Enzyme InhibitorsDrug IndustryCost SharingMedicare Part DAngiotensin Receptor AntagonistsShockAminobutyrates

• DIRECT-TO-PHYSICIAN MARKETING AND ADOPTION OF GUIDELINE-DIRECTED MEDICAL THERAPY IN MEDICARE PART D.
  Journal of the American College of Cardiology 2024 Colette DeJong, Kosuke Inoue, Matthew Durstenfeld, Anubha Agarwal, Justin C. Chen, Chien-Wen Tseng, R Adams Dudley, Priscilla Y. Hsue, Dhruv Kazi
• PATIENT AND PROVIDER PERSPECTIVES ON A POLYPILL FOR HEART FAILURE WITH REDUCED EJECTION FRACTION.
  Journal of the American College of Cardiology 2024 Justin C. Chen, Colette DeJong, Amaris M. Hairston, Matthew Durstenfeld, Priscilla Y. Hsue, Mark D. Huffman, Anubha Agarwal
• Abstract 15872: Development and External Validation of a De Novo Simulation Model to Inform Implementation Strategies for Guideline-Directed Medical Therapy of Heart Failure With Reduced Ejection Fraction.
  Circulation 2023 Julia H Foote, Ambarish Pandey, Anubha Agarwal, Brandon K Bellows, Colette DeJong, Priscilla Y Hsue, Dhruv S Kazi
• The Inflation Reduction Act and Out-of-Pocket Drug Costs for Medicare Beneficiaries With Cardiovascular Disease.
  Journal of the American College of Cardiology 2023 Kazi DS, DeJong C, Chen R, Wadhera RK, Tseng CW
• IMPACT OF THE $35 INSULIN PROGRAM ON OUT-OF-POCKET COSTS UNDER MEDICARE PART D.
  Journal of the American College of Cardiology 2023 Colette Dejong, Randi Chen, Camlyn Masuda, Chien-Wen Tseng

Show all (32 more) Hide

• PROJECTED IMPACT OF THE INFLATION REDUCTION ACT ON OUT-OF-POCKET DRUG COSTS FOR MEDICARE PART D BENEFICIARIES WITH CARDIOVASCULAR DISEASE.
  Journal of the American College of Cardiology 2023 Dhruv Kazi, Colette Dejong, Rishi Wadhera, Randi Chen, Chien-Wen Tseng
• THE INFLATION REDUCTION ACT WILL CHANGE WHO PAYS FOR CARDIOVASCULAR DRUGS UNDER MEDICARE PART D.
  Journal of the American College of Cardiology 2023 Dhruv Kazi, Colette DeJong, Randi Chen, Chien-Wen Tseng
• Spending on Insulin by U.S. Payers and Patients From 2008 to 2017.
  Diabetes care 2022 Chiu N, Aggarwal R, Hernandez I, Wadhera R, Dejong C, Tseng CW, Yeh RW, Kazi DS
• A Pilot Program to Teach Pharmacy Students Practical Skills to Navigate Drug Insurance Benefits.
  Pharmacy (Basel, Switzerland) 2022 Masuda C, Huynh T, Wong V, DeJong C, Tseng CW
• Patients' Compliance With Quarantine Requirements for Exposure or Potential Symptoms of COVID-19.
  Hawai'i journal of health & social welfare 2021 Tseng CW, Roh Y, DeJong C, Kanagusuku LN, Soin KS
• Association Between Industry Marketing Payments and Prescriptions for PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibitors in the United States.
  Circulation. Cardiovascular quality and outcomes 2021 Inoue K, Figueroa JF, DeJong C, Tsugawa Y, Orav EJ, Shen C, Kazi DS
• Trends in the Use of Angiotensin-Converting Enzyme Inhibitor and Angiotensin-II Receptor Blocker Among United States Adults From 1999 to 2018.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2021 Inoue K, DeJong C, Nangaku M
• Deferral of Care for Serious Non-COVID-19 Conditions: A Hidden Harm of COVID-19.
  JAMA internal medicine 2021 DeJong C, Katz MH, Covinsky K
• Out-of-Pocket Costs for Novel Guideline-Directed Diabetes Therapies Under Medicare Part D.
  JAMA internal medicine 2020 DeJong C, Masuda C, Chen R, Kazi DS, Dudley RA, Tseng CW
• Inclusion Across the Lifespan in Cardiovascular Trials-A Long Road Ahead.
  JAMA internal medicine 2020 DeJong C, Covinsky K
• Multivessel or Culprit Vessel-Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK.
  JAMA internal medicine 2020 DeJong C, Redberg RF
• The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19-First, Do No Harm.
  JAMA internal medicine 2020 DeJong C, Wachter RM
• An Ethical Framework for Allocating Scarce Inpatient Medications for COVID-19 in the US.
  JAMA 2020 DeJong C, Chen AH, Lo B
• Addressing Mistreatment in Medical Education.
  JAMA internal medicine 2020 Thakkar AB, Dejong C, Katz MH
• Continuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Face of Kidney Disease Progression-Safe and Possibly Life Saving.
  JAMA internal medicine 2020 DeJong C, Grant RW
• Disclosure of Article Funding and Conflicts of Interest in High-Impact Clinical Journals.
  Journal of general internal medicine 2020 Anderson TS, DeJong C, Good CB, Gellad WF
• Shining a Light on Industry Payments to Health Care Professionals Who Are Not Physicians.
  JAMA internal medicine 2019 DeJong C, Steinbrook R
• Assessment of National Coverage and Out-of-Pocket Costs for Sacubitril/Valsartan Under Medicare Part D.
  JAMA cardiology 2019 DeJong C, Kazi DS, Dudley RA, Chen R, Tseng CW
• Supplemental Security Income and the Health of Low-Income Adults.
  JAMA internal medicine 2019 DeJong C, Katz MH
• Electrocardiographic Harbingers of Ventricular Tachycardia Arrest-A Moment of Pause.
  JAMA internal medicine 2019 DeJong C, Nishtala A, Goldschlager N
• Validation of Prediction Models for Critical Care Outcomes Using Natural Language Processing of Electronic Health Record Data.
  JAMA network open 2018 Marafino BJ, Park M, Davies JM, Thombley R, Luft HS, Sing DC, Kazi DS, DeJong C, Boscardin WJ, Dean ML, Dudley RA
• Continuing Problems With Financial Conflicts of Interest and Clinical Practice Guidelines.
  JAMA internal medicine 2018 DeJong C, Steinbrook R
• Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans.
  JAMA cardiology 2017 Kazi DS, Lu CY, Lin GA, DeJong C, Dudley RA, Chen R, Tseng CW
• MEDICARE PART D—COST BURDEN OF INHALED DRUGS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
  Innovation in Aging 2017 C. Tseng, J. Yazdany, R. Dudley, C. Dejong, D. Kazi, R. Chen, G. Lin
• Reconsidering Physician-Pharmaceutical Industry Relationships.
  JAMA 2017 DeJong C, Dudley RA
• Medicare Part D Plans' Coverage and Cost-Sharing for Acute Rescue and Preventive Inhalers for Chronic Obstructive Pulmonary Disease.
  JAMA internal medicine 2017 Tseng CW, Yazdany J, Dudley RA, DeJong C, Kazi DS, Chen R, Lin GA
• Important Distinctions Concerning Pharmaceutical Company-Sponsored Meals and Prescribing Patterns-Reply.
  JAMA internal medicine 2016 DeJong C, Tseng CW, Dudley RA
• Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries.
  JAMA internal medicine 2016 DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA
• Variation in Quality of Urgent Health Care Provided During Commercial Virtual Visits.
  JAMA internal medicine 2016 Schoenfeld AJ, Davies JM, Marafino BJ, Dean M, DeJong C, Bardach NS, Kazi DS, Boscardin WJ, Lin GA, Duseja R, Mei YJ, Mehrotra A, Dudley RA
• Incorporating a New Technology While Doing No Harm, Virtually.
  JAMA 2015 DeJong C, Lucey CR, Dudley RA
• Websites that offer care over the Internet: is there an access quality tradeoff?
  JAMA 2014 DeJong C, Santa J, Dudley RA
• Short communication: new HIV infections at Southern New England academic institutions: implications for prevention.
  AIDS research and human retroviruses 2012 Chan PA, Kazi S, Rana A, Blazar I, Dejong CC, Mayer KH, Huard TK, Carleton K, Gillani F, Alexander N, Parillo Z, Flanigan TP, Kantor R